EP 1030651 A1 20000830 - NOVEL ORAL DOSAGE FORM FOR CARVEDILOL
Title (en)
NOVEL ORAL DOSAGE FORM FOR CARVEDILOL
Title (de)
NEUARTIGE ORALE VERABREICHUNGSFORM FÜR CARVEDILOL
Title (fr)
NOUVELLE FORME POSOLOGIQUE PAR VOIE ORALE POUR LE CARVEDILOL
Publication
Application
Priority
- US 9824102 W 19981112
- US 6545697 P 19971112
Abstract (en)
[origin: WO9924017A1] The present invention discloses a matrix formulation containing carvedilol.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 9/30 (2006.01); A61K 9/50 (2006.01); A61K 31/403 (2006.01); A61K 47/10 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61P 9/00 (2006.01); A61K 9/28 (2006.01)
CPC (source: EP KR)
A61K 9/10 (2013.01 - KR); A61K 9/2027 (2013.01 - EP); A61K 9/2054 (2013.01 - EP); A61K 9/5078 (2013.01 - EP); A61P 9/00 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61K 9/2018 (2013.01 - EP); A61K 9/2077 (2013.01 - EP); A61K 9/2846 (2013.01 - EP); A61K 9/2866 (2013.01 - EP); A61K 9/5015 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9924017 A1 19990520; AU 1456999 A 19990531; AU 751117 B2 20020808; BR 9814127 A 20001003; CA 2309542 A1 19990520; CN 1285738 A 20010228; EP 1030651 A1 20000830; EP 1030651 A4 20060531; HU P0004345 A2 20010628; HU P0004345 A3 20011029; IL 136028 A0 20010520; JP 2001522794 A 20011120; KR 20010031952 A 20010416; NO 20002439 D0 20000511; NO 20002439 L 20000511; NZ 504418 A 20030228; PL 340456 A1 20010212; TR 200001362 T2 20000921
DOCDB simple family (application)
US 9824102 W 19981112; AU 1456999 A 19981112; BR 9814127 A 19981112; CA 2309542 A 19981112; CN 98813082 A 19981112; EP 98958546 A 19981112; HU P0004345 A 19981112; IL 13602898 A 19981112; JP 2000520110 A 19981112; KR 20007005059 A 20000510; NO 20002439 A 20000511; NZ 50441898 A 19981112; PL 34045698 A 19981112; TR 200001362 T 19981112